Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

The Effect of Liraglutide Versus Placebo When Added to Basal Insulin Analogues With or Without Metformin in Subjects With Type 2 Diabetes

ClinicalTrials.gov ID: NCT01617434

Public ClinicalTrials.gov record NCT01617434. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 4, 2026, 8:26 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Study identification

NCT ID
NCT01617434
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Novo Nordisk A/S
Industry
Enrollment
451 participants

Conditions and interventions

Interventions

  • liraglutide Drug
  • placebo Drug

Drug

Eligibility (public fields only)

Age range
18 Years to 80 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Aug 31, 2012
Primary completion
Sep 30, 2013
Completion
Sep 30, 2013
Last update posted
Mar 7, 2017

2012 – 2013

United States locations

U.S. sites
31
U.S. states
20
U.S. cities
30
Facility City State ZIP Site status
Novo Nordisk Investigational Site Phoenix Arizona 85020
Novo Nordisk Investigational Site Anaheim California 92801
Novo Nordisk Investigational Site Fresno California 93726
Novo Nordisk Investigational Site Los Angeles California 90057
Novo Nordisk Investigational Site San Mateo California 94401
Novo Nordisk Investigational Site San Ramon California 94583
Novo Nordisk Investigational Site Tustin California 92780-7045
Novo Nordisk Investigational Site Ventura California 93003
Novo Nordisk Investigational Site Walnut Creek California 94598
Novo Nordisk Investigational Site Kissimmee Florida 34741
Novo Nordisk Investigational Site Gurnee Illinois 60031
Novo Nordisk Investigational Site Greenfield Indiana 46140
Novo Nordisk Investigational Site Lexington Kentucky 40503
Novo Nordisk Investigational Site Metairie Louisiana 70002
Novo Nordisk Investigational Site Rockville Maryland 20852
Novo Nordisk Investigational Site Methuen Massachusetts 01844
Novo Nordisk Investigational Site Omaha Nebraska 68114
Novo Nordisk Investigational Site Newington New Hampshire 03801
Novo Nordisk Investigational Site Greensboro North Carolina 27401-1023
Novo Nordisk Investigational Site McMurray Pennsylvania 15317
Novo Nordisk Investigational Site Spartanburg South Carolina 29303
Novo Nordisk Investigational Site Kingsport Tennessee 37660
Novo Nordisk Investigational Site Dallas Texas 75230
Novo Nordisk Investigational Site San Antonio Texas 78215
Novo Nordisk Investigational Site San Antonio Texas 78224
Novo Nordisk Investigational Site Sugarland Texas 77478
Novo Nordisk Investigational Site Salt Lake City Utah 84107
Novo Nordisk Investigational Site Midlothian Virginia 23114
Novo Nordisk Investigational Site Richmond Virginia 23219
Novo Nordisk Investigational Site Renton Washington 98057
Novo Nordisk Investigational Site Martinsburg West Virginia 25401

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 55 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT01617434, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Mar 7, 2017 · Synced May 4, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT01617434 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →